Lee Rosebush, warning in a press release that the move could have “tremendous implications” for patients and doctors given the sheer volume of demand for the drugs at issue. Lilly's Zepbound ...
The Tennessee Titans have achieved true betting infamy this NFL season. At 2-14 against the spread, the Titans currently have the worst against the spread record of any team in the Super Bowl era ...
Novo and Lilly have both been on a manufacturing expansion tear in 2024, lining up multiple high-profile production projects around the world. To name just a few investments, Novo has blueprinted ...
Lee was diagnosed with a degenerative brain disease in October, before further testing revealed that he had ALS earlier this month. ALS, also known as Lou Gehrig’s disease, is a progressive and ...
whose investigation into Cambridge Analytica earned her a nomination for the Pulitzer Prize in 2019. The journalist is also well known for her long-running legal row with Brexit campaigner Arron ...
The highly anticipated second installment premieres Dec. 26 on Netflix Esther Kang is a writer at PEOPLE. She has been working at PEOPLE since 2023 and has previously worked for publications like ...
Pulitzer famously sourced much of her fabric and all of her prints from Key West Hand Print Fabrics Co. from 1962 to 1985. Lilly Pulitzer officials said in a news release that the prints are ...
The Palm Beach-founded fashion brand announced this week that it now owns the copyright to the library of prints from 1962 to 1985 that were created by Key West Hand Print Fabrics Co. and its lead ...
Eli Lilly announced FDA approval of Zepbound as the first prescription medicine for adults with moderate-to-severe obstructive sleep apnea. In addition, adults on Zepbound lost an average of 45 ...
Eli Lilly sells one of the most sought-after types of drugs today: weight loss drugs. The company’s Zepbound and Mounjaro have brought in blockbuster revenue, and more growth could be on the ...
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today. From reproductive rights to climate change to Big Tech, The ...
On Friday, the federal agency green-lighted Eli Lilly’s Zepbound drug for the use, approving a prescription medicine suited for adults suffering from moderate to severe obstructive sleep apnea ...